The analysis of the <scp>circRNAs</scp> in the progress of acquired resistance to Cetuximab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The analysis of the circRNAs in the progress of acquired resistance to Cetuximab

Published:2022-06 Issue:2 Volume:11 Page:51-55
ISSN:2642-2514
Container-title:Precision Medical Sciences
language:en
Short-container-title:Precision Medical Sciences

Author:

Yin Liping¹^ORCID,Jing Changwen¹^ORCID,Guo Yesong²

Affiliation:

1. Department of Geriatrics Nanjing Lishui people's hospital Nanjing China

2. Department of Radiation Oncology Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University Nanjing China

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prm2.12066

Reference20 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Cancer statistics in China, 2015

3. Clinical utility of circulating non-coding RNAs — an update

4. The biogenesis, biology and characterization of circular RNAs

5. Circular RNAs in cancer and diabetes

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP